# Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis

> **NCT02557100** · PHASE4 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 80 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Abatacept
- **DRUG:** Adalimumab
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT02557100
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-19
- **Primary completion:** 2019-03-28
- **Final completion:** 2019-03-28
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02557100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02557100, "Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02557100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*